11.04.19

Trump to Nominate Stephen Hahn, Cancer Researcher, to Head FDA

Source: The New York Times

President Trump said Friday that he intended to nominate Stephen M. Hahn, MD, a top executive at The University of Texas M.D. Anderson Cancer Center, to be the next commissioner of the Food and Drug Administration, according to a report in The New York Times.

If he is confirmed by the Senate, Dr. Hahn would fill the vacancy left by Dr. Scott Gottlieb, who stepped down as commissioner in April. In doing so, he passed over the acting commissioner, Dr. Norman E. Sharpless, who had the support of previous commissioners and an array of patient groups.

Read the full article.

Related Content